Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

Talis Biomedical Q2 EPS $(2.51) Misses $(0.91) Estimate

Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $(0.91) by 175.82 percent.

byBill Haddad

August 10, 2021

1 minute read

Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $(0.91) by 175.82 percent.